EDGAR Filing Documents for 0001193125-11-310818

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001193125-11-310818

Filing Date

2011-11-14

Accepted

2011-11-14 16:01:11

Documents

Period of Report

2011-09-30

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-Q	d239872d10q.htm	10-Q	265082
2	SECTION 302 CERTIFICATION OF CEO	d239872dex311.htm	EX-31.1	10150
3	SECTION 302 CERTIFICATION OF CFO	d239872dex312.htm	EX-31.2	10163
4	SECTION 906 CERTIFICATION OF CEO AND CFO	d239872dex32.htm	EX-32	5667
	Complete submission text file	0001193125-11-310818.txt		1142333

Data Files

Seq	Description	Document	Type	Size
5	XBRL INSTANCE DOCUMENT	corx-20110930.xml	EX-101.INS	104022
6	XBRL TAXONOMY EXTENSION SCHEMA	corx-20110930.xsd	EX-101.SCH	8252
7	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	corx-20110930_cal.xml	EX-101.CAL	30428
8	XBRL TAXONOMY EXTENSION LABEL LINKBASE	corx-20110930_lab.xml	EX-101.LAB	93235
9	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	corx-20110930_pre.xml	EX-101.PRE	61055

Mailing Address 15241 BARRANCA PARKWAY IRVINE CA 92718

Business Address 15241 BARRANCA PKWY IRVINE CA 92718 7147273157

CORTEX PHARMACEUTICALS INC/DE/ (Filer) CIK: 0000849636 (see all company filings)